Showing posts with label private equity. Show all posts
Showing posts with label private equity. Show all posts

Wednesday, July 4, 2007

Apollo Trumps Basell with $10.4 Billion Huntsman Bid

Hexion Specialty Chemicals, owned by private equity firm Apollo Management, has launched a $10.4 billion, or $27.25/share, bid to acquire Huntsman, topping Basell’s previously announced $25.25/share agreement to acquire the company. Huntsman says that a committee of independent directors is evaluating the Hexion bid and “are engaged in discussions with Hexion regarding their proposal.” Basell is entitled to a $200 million payment if Huntsman accepts a higher bid, according to Huntsman. Hexion has agreed to fund $100 million of this payment, according to Huntsman. Hexion has leading positions in epoxy, phenolic, and formaldehyde-based resins as well as coatings and inks. There is overlap in the epoxies business. Hexion says it has a leading 34% global market share in epoxy resins. Huntsman currently ranks third in epoxies globally, and Hexion could be required to divest all or part of Huntsman’s epoxy business to gain antitrust approvals, analysts say. Dow Chemical is the other leading global epoxy producer, and the top-three producers account for about 75% of global capacity for epoxy resins, according to SRI Consulting (Menlo Park, CA). Hexion’s proposal includes a $325 million reverse break-up fee payable by Hexion to Huntsman “in the event the transaction does not close due to the failure to obtain regulatory clearance or requisite financing,” Huntsman says. The Huntsman family and investment firm MatlinPatterson together control a trust that owns 59% of Huntsman stock. MatlinPatterson owns about 55% of that trust, but the Huntsman family retains voting control of the trust, and, in effect, operating control of the company. Huntsman spurned offers from private equity buyers last year, including Apollo, that were in the low-$20/share range last year. Company founder and chairman Jon Huntsman told analysts at a Huntsman investor meeting earlier this year that the company was not for sale “unless I know I can get maximum dollar. I’m not going to give up what I’ve worked my entire life to build when someone comes in with an offer of $23-$24 /share.”

Monday, April 9, 2007

The Rumor(s) That Won’t Go Away

By ROB WESTERVELT (Editor, Chemical Week)
Dow Chemical is the subject of speculative frenzy again after the British tabloid Sunday Express reported yesterday that a group of Middle East investors and U.S. buyout firms was preparing a $50-billion takeover bid for the company. The same paper reported two months ago that a buyout bid for Dow Chemical was imminent.
Dow chairman and CEO Andrew Liveris tried to squelch such reports last month at the BB&T Manufacturing & Materials Conference in New York, asking investors to reject fantastical reports emanating from the “third-rate press.” CW could fill an issue with the rumors and speculation that we’ve picked up about Dow Chemical in the past three months. Reports of an imminent leveraged buyout (LBO) or basic chemical sale or jv have come and gone in recent weeks. The speculation is being fueled by Dow’s low stock price and the amount of cash it generates. Those figures have caught the attention of any investor with the wherewithal to pull off a deal in the $50-billion range. Private equity may be knocking but Dow hasn’t answered yet. And it doesn’t appear likely that Dow management is willing to put the company in play for a bid in the 50's/share range.